About Apimeds Pharmaceuticals US, Inc (APUS) data

Data as of September 30, 2026.

Apimeds Pharmaceuticals US, Inc (APUS) has 79.54K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 668.79% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.01 days (days to cover).

Frequently asked questions

What is the current short interest in APUS?

As of the latest FINRA settlement dated September 30, 2026, APUS had approximately 79,539 shares sold short. Short interest data is reported by FINRA twice per month.

How much does it cost to short APUS?

The latest borrow fee (cost to borrow) for APUS is 636.56% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.

What is the days to cover ratio for APUS?

Days to cover for APUS is approximately 0.01 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.

Is APUS on the Reg SHO threshold list?

Yes. On the latest list, APUS has been on the NYSE American Reg SHO threshold list for 4 consecutive settlement days, since October 13, 2026. A stock is listed after five consecutive settlement days with fails to deliver of at least 10,000 shares and 0.5% of shares outstanding.

How many APUS shares failed to deliver?

On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 8,068 shares of APUS had failed to deliver, worth about $40.50K at the prior day's close (0.53% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.

Is APUS a short squeeze candidate?

A squeeze needs shorts that are hard to close. APUS trades about 11,747,902 shares a day and would take roughly 0.01 days to unwind current short positions, at a current borrow fee of 636.56%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.

Not investment advice. Past performance does not guarantee future results.

Welcome Back

Sign in to your account

or
Forgot password?

Create Account

or